Lei Zhang1, Huizhang Zhang2, Zhichao Zhu3, Lijia Jiang3, Xuzhang Lu4, Min Zhou4, Xiao Sun3, Liuyang He3, Yu Bai3, Lingdi Ma3. 1. Department of Advanced Medical Service, Tongji Hospital, Tongji University Shanghai 200065, China. 2. Department of Laboratory Medicine, Jinshan Hospital, Fudan University Shanghai 201508, China. 3. Laboratary Center, Changzhou No. 2 People's Hospital, The Affiliated Hospital of Nanjing Medical University Changzhou 213000, China. 4. Department of Hematology, Changzhou No. 2 People's Hospital, The Affiliated Hospital of Nanjing Medical University Changzhou 213000, China.
Abstract
AIMS: To investigate the roles of matrine in regulating immune functions and its effect on the proliferation of leukemic cells. METHODS: Human leukemia K562, OUN-1, HL-60, U937, K562/AO2 cell lines and primary leukemic cells were used to detect the NKG2D ligands (NKG2DL) expression such as MICA/B, ULBP-1, ULBP-2, ULBP-3, and NK cells receptor NKG2D, CD158a, CD158b were detected by flow cytometry. Cell cytotoxic activity of human NK cells and CIK cells against K562 leukemia cells was detected using CFSE/PI double staining. Pro-inflammatory cytokines and adhesion molecules in K562 or NK cells supernatant after matrine treatment were detected. RESULTS: Matrine could upregulate the expression of NKG2DL on leukemic cell lines, and primary leukemic cells and enhance the NK and CIK cytotoxicity targeted to K562 cells. After matrine treatment, pro-inflammatory cytokines and adhesion molecular such as IL-6, IL-1, IL-2, IL-4, IL-5, GRO and TNF-α in K562 cells supernatant were significantly decreased (P < 0.05). Flow cytometry analysis showed that the NKG2D expression was up-regulated significantly as well as the CD158a and CD158b expression decreased after treatment with different concentration of matrine in a dose-dependent manner in K562 cells. A significant decrease of supernatant concentrations of IL-1α, IL-5, IL-6, IL-10, IFN-γ, GRO and TNF-α in NK cells was also observed after exposure to the matrine. CONCLUSION: Matrine regulates immune functions to inhibit the proliferation of leukemic cells.
AIMS: To investigate the roles of matrine in regulating immune functions and its effect on the proliferation of leukemic cells. METHODS:Humanleukemia K562, OUN-1, HL-60, U937, K562/AO2 cell lines and primary leukemic cells were used to detect the NKG2D ligands (NKG2DL) expression such as MICA/B, ULBP-1, ULBP-2, ULBP-3, and NK cells receptor NKG2D, CD158a, CD158b were detected by flow cytometry. Cell cytotoxic activity of human NK cells and CIK cells against K562 leukemia cells was detected using CFSE/PI double staining. Pro-inflammatory cytokines and adhesion molecules in K562 or NK cells supernatant after matrine treatment were detected. RESULTS:Matrine could upregulate the expression of NKG2DL on leukemic cell lines, and primary leukemic cells and enhance the NK and CIK cytotoxicity targeted to K562 cells. After matrine treatment, pro-inflammatory cytokines and adhesion molecular such as IL-6, IL-1, IL-2, IL-4, IL-5, GRO and TNF-α in K562 cells supernatant were significantly decreased (P < 0.05). Flow cytometry analysis showed that the NKG2D expression was up-regulated significantly as well as the CD158a and CD158b expression decreased after treatment with different concentration of matrine in a dose-dependent manner in K562 cells. A significant decrease of supernatant concentrations of IL-1α, IL-5, IL-6, IL-10, IFN-γ, GRO and TNF-α in NK cells was also observed after exposure to the matrine. CONCLUSION:Matrine regulates immune functions to inhibit the proliferation of leukemic cells.
Entities:
Keywords:
Matrine; NK cells; immune functions; luekemia cells
Authors: Gordon P Meares; Yudong Liu; Rajani Rajbhandari; Hongwei Qin; Susan E Nozell; James A Mobley; John A Corbett; Etty N Benveniste Journal: Mol Cell Biol Date: 2014-08-11 Impact factor: 4.272
Authors: N Kato; J Tanaka; J Sugita; T Toubai; Y Miura; M Ibata; Y Syono; S Ota; T Kondo; M Asaka; M Imamura Journal: Leukemia Date: 2007-07-12 Impact factor: 11.528
Authors: Ali Awad; Hanane Yassine; Mathieu Barrier; Han Vorng; Philippe Marquillies; Anne Tsicopoulos; Catherine Duez Journal: PLoS One Date: 2014-04-11 Impact factor: 3.240